Publications by authors named "Thomas Felzmann"

Claim this Profile
T
Towards integrating imaging and immunology in glioblastoma: mapping blood immune system metrics to tumor magnetic resonance image data.
Johanna Heugenhauser, Carmen Visus, Johanna Buchroithner, Christine Marosi, Karl Rössler, Thomas Felzmann

Acta Neuropathol Commun· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MRI Response Assessment in Glioblastoma Patients Treated with Dendritic-Cell-Based Immunotherapy.
Johanna Heugenhauser, Malik Galijasevic, Stephanie Mangesius, Georg Goebel, Johanna Buchroithner, Thomas Felzmann

Cancers (Basel)· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined proteomics/miRNomics of dendritic cell immunotherapy-treated glioblastoma patients as a screening for survival-associated factors.
Friedrich Erhart, Matthias Hackl, Hannes Hahne, Johanna Buchroithner, Chen Meng, Thomas Felzmann

NPJ Vaccines· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spheroid glioblastoma culture conditions as antigen source for dendritic cell-based immunotherapy: spheroid proteins are survival-relevant targets but can impair immunogenic interferon γ production.
Friedrich Erhart, Tamara Weiss, Simone Klingenbrunner, Katrin Fischhuber, René Reitermaier, Thomas Felzmann

Cytotherapy· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunological analysis of phase II glioblastoma dendritic cell vaccine (Audencel) trial: immune system characteristics influence outcome and Audencel up-regulates Th1-related immunovariables.
Friedrich Erhart, Johanna Buchroithner, René Reitermaier, Katrin Fischhuber, Simone Klingenbrunner, Thomas Felzmann

Acta Neuropathol Commun· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Audencel Immunotherapy Based on Dendritic Cells Has No Effect on Overall and Progression-Free Survival in Newly Diagnosed Glioblastoma: A Phase II Randomized Trial.
Johanna Buchroithner, Friedrich Erhart, Josef Pichler, Georg Widhalm, Matthias Preusser, Thomas Felzmann

Cancers (Basel)· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The MAPK-Activated Kinase MK2 Attenuates Dendritic Cell-Mediated Th1 Differentiation and Autoimmune Encephalomyelitis.
Klara Soukup, Angela Halfmann, Marie Le Bras, Emine Sahin, Sarah Vittori, Thomas Felzmann

J Immunol· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic dendritic cell-based cancer vaccines: the state of the art.
Marius M Strioga, Thomas Felzmann, Daniel J Powell, Valerijus Ostapenko, Neringa T Dobrovolskiene

Crit Rev Immunol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vascular endothelia growth factor targeted therapy may improve the effect of dendritic cell-based cancer immune therapy.
Johanna Buchroithner, Josef Pichler, Christine Marosi, Georg Widhalm, Marcel Seiz-Rosenhagen, Thomas Felzmann

Int J Clin Pharmacol Ther· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toll-like receptor 4 engagement drives differentiation of human and murine dendritic cells from a pro- into an anti-inflammatory mode.
Romana Luger, Sneha Valookaran, Natalie Knapp, Caterina Vizzardelli, Alexander M Dohnal, Thomas Felzmann

PLoS One· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune suppression by gammadelta T-cells as a potential regulatory mechanism after cancer vaccination with IL-12 secreting dendritic cells.
Michael W Traxlmayr, Daniela Wesch, Alexander M Dohnal, Philipp Funovics, Michael B Fischer, Thomas Felzmann

J Immunother· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interferon-gamma-triggered indoleamine 2,3-dioxygenase competence in human monocyte-derived dendritic cells induces regulatory activity in allogeneic T cells.
Birgit Jürgens, Ursula Hainz, Dietmar Fuchs, Thomas Felzmann, Andreas Heitger

Blood· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fourth Medical Biotech Forum of the Chinese Medical Biotech Association. 8-10 August 2009, Dalian, China.
Thomas Felzmann

IDrugs· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD40 ligation restores type 1 polarizing capacity in TLR4-activated dendritic cells that have ceased interleukin-12 expression.
Alexander Michael Dohnal, Romana Luger, Petra Paul, Dietmar Fuchs, Thomas Felzmann

J Cell Mol Med· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative evaluation of techniques for the manufacturing of dendritic cell-based cancer vaccines.
Alexander Michael Dohnal, Sebastian Graffi, Volker Witt, Christina Eichstill, Dagmar Wagner, Thomas Felzmann

J Cell Mol Med· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of an indispensable role for tyrosine kinase 2 in CTL-mediated tumor surveillance.
Olivia Simma, Eva Zebedin, Nina Neugebauer, Carola Schellack, Andreas Pilz, Thomas Felzmann

Cancer Res· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leukemia-associated antigenic isoforms induce a specific immune response in children with T-ALL.
Alexander Michael Dohnal, Andrea Inthal, Thomas Felzmann, Sebastian Glatt, Wolfgang Sommergruber

Int J Cancer· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Semi-mature IL-12 secreting dendritic cells present exogenous antigen to trigger cytolytic immune responses.
Thomas Felzmann, Katharina Gabriele Hüttner, Sabine Konstanze Breuer, Doris Wimmer, Gabriele Ressmann

Cancer Immunol Immunother· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation of potent anti-tumor immunity in mice by interleukin-12-secreting dendritic cells.
Katharina Gabriele Hüttner, Sabine Konstanze Breuer, Petra Paul, Otto Majdic, Andreas Heitger, Thomas Felzmann

Cancer Immunol Immunother· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MHC class II antigen signaling induces homotypic and heterotypic cluster formation of human mature monocyte derived dendritic cells in the absence of cell death.
Manfred Lehner, Johannes Stöckl, Otto Majdic, Walter Knapp, Katharina Hüttner, Thomas Felzmann

Hum Immunol· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis